News About: Pharm. Industry
Bioventure firms to launch BT based products
Business sources say that a serious of products based on the biotechnology has been launched in the domestic market, and have further noted that:
- Ventri developed a special nutrition product Alcabas containing se...
Government drug policy may fuel more illicit transaction
Market observers say that the inconsistent drug related policies of the government designed to unilaterally reduce the insurance drug prices for better finance stability in the national health insurance sector, has ra...
Scigenic to export US$30 million worth of natural product
Scigenic, a local bioventure firm, says that it signed with Celture Chem. of the US, a health food manufacturer, for its export of INM176, a health food ingredient for the prevention or treatment of dementia.
Unde...
International discussion on the protection of IPR in bioindustry getting heated
Stimulated by more heated international discussion of various international organizations on the protection of intellectual property rights in bioindustry sectors, the Korean Industrial Property Office will closely co...
Top selling drugs kept its pace this year too.
90 top sellers sold by 37 drug companies as much as over 10 billion won still showed a sustained rising pace this year ensuing the past.
The data collected by Bestcare (Dec. last year and Jan/Feb this year) showed...
Active R&D-investment may guarantee better financial indicators of enterprises
Professor Cho Sung-pyo, department of business administration of Kyungbuk University, has analyzed the correlation between R&D investment and outcomes of the enterprises (e.g.: profitability, growth, productivity, and...
Electronic commerce to provide 6 month credit terms.
An electronic commerce company named Ahyah. com (www.ahyah.com) has successfully established an ERP (Enterprise Resource Planning) system providing 6 months credit for the drug trade among the drug makers, wholesalers...
Recognition of drug margin will trigger unfair trade competition
The domestic pharmaceutical industry has recently denounced the government's drug related policy to allow the drug margin up to 50 percent on the medical institutions which will purchase the lowest insurance-covered d...
Market price of Glivec disputed
The Joint Countermeasure Committee for making Glivec available to Korean patients with chronic myeloid leukemia (CML) has recently urged that the government should forcibly enforce the public price of Glivec at the pr...
Full assistance for small- and mid-sized firms eyed
The Korean Drug Association (KDA) says it will make this year for concentrating efforts to actually support the small-and mid-sized firms through offerings of a low-interest fund and discounting of a bill, in a move t...
